No Matches Found
No Matches Found
No Matches Found
Fischer Medical Ventures Ltd
Fischer Medical Ventures Gains 2.02%: 2 Key Events Driving the Week
Fischer Medical Ventures Ltd experienced a mixed week from 27 to 31 July 2026, ultimately closing with a modest gain of 2.02% to Rs.38.95, slightly underperforming the Sensex which rose 2.39% over the same period. The stock faced early selling pressure with three consecutive days of decline before rebounding sharply on 30 July, driven by robust buying momentum that propelled it to an upper circuit limit. This week’s price action was marked by heightened volatility and significant volume spikes, reflecting renewed investor interest despite the company’s recent Sell rating by MarketsMOJO.
Above All Moving Averages and Now at Upper Circuit: Fischer Medical Ventures Ltd Gains 7.63% in a Single Session
At Rs 39.33, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Fischer Medical Ventures Ltd locked at its upper circuit of 7.63% on 29 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Fischer Medical Ventures Ltd Surges 7.39% to Day's High of Rs 38.32 — Outperforms Sector by 6.37 Percentage Points
The Sensex edged down 0.06% on 30 Jul 2026, while Fischer Medical Ventures Ltd surged 7.39%, marking a notable 6.37 percentage-point outperformance over its Commodity Chemicals sector peers. This sharp intraday gain rewrites the short-term narrative for the stock, which had been under pressure in recent weeks.
Fischer Medical Ventures Ltd is Rated Sell
Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Fischer Medical Ventures Ltd is Rated Sell
Fischer Medical Ventures Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Fischer Medical Ventures Ltd is Rated Sell
Fischer Medical Ventures Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Fischer Medical Ventures Ltd Surges 8.44% to Day's High of Rs 41.96 — Outperforms Sector by 6.73 Percentage Points
The Sensex declined 0.41% on 30 Jun 2026, while Fischer Medical Ventures Ltd surged 8.44%, reaching an intraday high of Rs 41.96. This 6.73-percentage-point outperformance over the Commodity Chemicals sector’s 2.62% gain highlights a distinctly stock-specific rally in a broadly weak market environment.
Fischer Medical Ventures Ltd is Rated Sell
Fischer Medical Ventures Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Fischer Medical Ventures Ltd Opens 9.31% Lower as Technicals Signal Continued Downside
Fischer Medical Ventures Ltd witnessed a significant gap down at the opening bell on 22 June 2026, reflecting heightened market apprehensions. The stock opened sharply lower by 9.31%, continuing a recent downward trend amid a broader underperformance relative to its sector and benchmark indices.
Fischer Medical Ventures Ltd Faces Mixed Technical Signals Amid Bearish Momentum
Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade from Hold to Sell by MarketsMOJO with a Mojo Score of 35.0, the stock’s price momentum and technical indicators reveal a nuanced picture that investors should carefully analyse.
Fischer Medical Ventures Ltd Falls 12.18%: Four Key Factors Behind the Sharp Decline
Fischer Medical Ventures Ltd experienced a turbulent week from 1 to 5 June 2026, with its stock price plunging 12.18% from Rs.38.11 to Rs.33.47, significantly underperforming the Sensex’s modest 0.78% decline. The week was marked by consecutive lower circuit hits, heavy selling pressure, and a technical downgrade that intensified bearish momentum, reflecting deteriorating investor sentiment and sectoral headwinds.
Fischer Medical Ventures Gains 8.16%: Key Drivers Behind the Weekly Rally
Fischer Medical Ventures Ltd’s stock experienced a volatile week from 8 to 12 June 2026, ultimately gaining 8.16% to close at Rs.36.20, significantly outperforming the Sensex’s modest 0.57% rise. The week was marked by a fresh 52-week low early on, followed by a sharp intraday surge midweek, reflecting a mix of bearish pressures and short-term bullish momentum amid broader market fluctuations.
Fischer Medical Ventures Ltd is Rated Sell
Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Fischer Medical Ventures Ltd Surges 8.7% to Day's High of Rs 34.47 — Outperforms Sector by 8.33 Percentage Points
The Sensex eked out a modest gain of 0.11% on 11 Jun 2026, but Fischer Medical Ventures Ltd surged 8.7%, outperforming its Commodity Chemicals sector by 8.33 percentage points. This sharp single-session advance stands out as a stock-specific event amid a broadly subdued market backdrop.
Fischer Medical Ventures Ltd Falls to 52-Week Low of Rs 32 as Sell-Off Deepens
Fischer Medical Ventures Ltd’s stock price declined to a fresh 52-week low of Rs.32 on 09 June 2026, marking a significant downturn for the commodity chemicals company amid a sustained negative trend over recent weeks.
Fischer Medical Ventures Ltd Falls to 52-Week Low of Rs 32 as Sell-Off Deepens
Fischer Medical Ventures Ltd’s stock price declined to a fresh 52-week low of Rs 32 on 8 June 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market, reflecting ongoing challenges in profitability and valuation metrics.
Fischer Medical Ventures Ltd Faces Bearish Momentum Amid Technical Downgrade
Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMOJO on 28 April 2026. The stock’s price has declined sharply, reflecting deteriorating technical indicators and a bearish outlook across multiple timeframes.
Fischer Medical Ventures Ltd Locks at Lower Circuit With 3.78% Loss — Sellers Queue, No Buyers in Sight
At Rs 34.43, sellers were still queuing — but there were no buyers willing to take the other side. Fischer Medical Ventures Ltd locked at its lower circuit of 3.78% on 2 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a thinly traded small-cap stock.
Fischer Medical Ventures Ltd Opens 5% Lower as Technicals Signal Continued Downside Pressure
Fischer Medical Ventures Ltd commenced trading on 2 June 2026 with a pronounced gap down, opening 5.0% lower than its previous close. This weak start reflects ongoing market apprehensions, with the stock underperforming its sector and broader indices amid a continuation of recent declines.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
